PDT Partners’s Medifast MED Stock Holding History

PDT Partners’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$348K	Buy	32,756 +2,033	+7%	+$23.4K	0.02%	430
2026 Q1	$313K	Buy	+30,723	New	+$331K	0.02%	462
2021 Q4	–	Sell	-3,000	Closed	-$578K	–	955
2021 Q3	$578K	Sell	3,000 -900	-23%	-$221K	0.04%	441
2021 Q2	$1.1M	Buy	+3,900	New	+$1.06M	0.07%	364
2016 Q4	–	Sell	-13,810	Closed	-$522K	–	537
2016 Q3	$522K	Buy	13,810 +200	+1%	+$7.17K	0.03%	369
2016 Q2	$453K	Hold	13,610	–	–	0.04%	337
2016 Q1	$411K	Buy	13,610 +3,900	+40%	+$114K	0.03%	435
2015 Q4	$295K	Sell	9,710 -32,641	-77%	-$972K	0.04%	318
2015 Q3	$1.14M	Sell	42,351 -17,683	-29%	-$515K	0.03%	677
2015 Q2	$1.94M	Buy	60,034 +38,634	+181%	+$1.23M	0.05%	441
2015 Q1	$641K	Buy	21,400 +4,200	+24%	+$133K	0.02%	929
2014 Q4	$577K	Buy	17,200 +5,441	+46%	+$169K	0.05%	429
2014 Q3	$386K	Sell	11,759 -3,527	-23%	-$108K	0.01%	1027
2014 Q2	$465K	Sell	15,286 -5,655	-27%	-$176K	0.01%	1046
2014 Q1	$609K	Buy	+20,941	New	+$561K	0.01%	849

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PDT Partners's MED Position: Q2 2026 in Review

PDT Partners increased its Medifast (MED) stake by 6.6% in Q2 2026, buying an estimated $23.4K and bringing the position to 32,756 shares worth $348K. The position accounts for 0.02% of the portfolio, ranked #430.

PDT Partners first reported a position in MED in Q1 2014 and has held it in 15 quarters since. The position peaked at $1.94M in Q2 2015. 112 funds tracked by Wall St. Rank hold MED as of Q2 2026.

PDT Partners held 32,756 shares of Medifast worth $348K as of Q2 2026.
PDT Partners bought 2,033 Medifast shares in Q2 2026, an estimated $23.4K.
Medifast made up 0.02% of PDT Partners's portfolio in Q2 2026, its #430 holding.
PDT Partners first reported a position in Medifast in Q1 2014 and has held it in 15 quarters since.
PDT Partners's Medifast position peaked at $1.94M in Q2 2015.
112 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.